Pharming Group N.V. Increase Decrease Through Exercise Of Options
Pharming Group N.V. (PHAR) reported Increase Decrease Through Exercise Of Options of $9.93 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions · last filed 2026-04-02
EUR
| Period end | Increase Decrease Through Exercise Of Options 12 month |
|---|---|
| 2020-12-31 | 2.36M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 2.71M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 7.79M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Increase Decrease Through Exercise Of Options 12 month |
|---|---|
| 2025-12-31 | $9.93M 20-F · filed 2026-04-02 |
| 2024-12-31 | $2.62M 20-F · filed 2026-04-02 |
| 2023-12-31 | $8.13M 20-F · filed 2026-04-02 |
| 2022-12-31 | $2.28M 20-F · filed 2025-04-03 |
| 2021-12-31 | $3.29M 20-F · filed 2024-04-04 |
| 2020-12-31 | $2.70M 20-F · filed 2023-04-05 |
| 2019-12-31 | $3.03M 20-F · filed 2022-04-06 |